LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Crossject

Similar companies to Crossject

Crossject Tech Stack

Crossject uses 8 technology products and services including jsDelivr, cdnjs, Underscore.js, and more. Explore Crossject 's tech stack below.

  • jsDelivr
    Content Delivery Network
  • cdnjs
    Content Delivery Network
  • Underscore.js
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Python
    Programming Languages
  • Bootstrap
    UI Frameworks
  • YouTube
    Video Players
  • Apache
    Web Servers

Crossject 's Email Address Formats

Crossject uses at least 1 format(s):
Crossject Email FormatsExamplePercentage
F.Last@crossject.comJ.Doe@crossject.com
46%
First.Last@crossject.comJohn.Doe@crossject.com
6%
FLast@crossject.comJDoe@crossject.com
2%
F.Last@crossject.comJ.Doe@crossject.com
46%

Frequently Asked Questions

Where is Crossject 's headquarters located?

Minus sign iconPlus sign icon
Crossject 's main headquarters is located at Parc MAZEN-SULLY 6-8 rue Pauline Kergomard Dijon, Bourgogne 21000 FR. The company has employees across 2 continents, including EuropeNorth America.

What is Crossject 's phone number?

Minus sign iconPlus sign icon
You can contact Crossject 's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Crossject 's official website and social media links?

Minus sign iconPlus sign icon
Crossject 's official website is crossject.com and has social profiles on LinkedIn.

What is Crossject 's NAICS code?

Minus sign iconPlus sign icon
Crossject 's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Crossject have currently?

Minus sign iconPlus sign icon
As of October 2024, Crossject has approximately 94 employees across 2 continents, including EuropeNorth America. Key team members include Chief Operating Officer - Specialty Pharma: O. G.Vice President Global Sales & Marketing: B. F.Vice President Us Business: D. Z.. Explore Crossject 's employee directory with LeadIQ.

What industry does Crossject belong to?

Minus sign iconPlus sign icon
Crossject operates in the Pharmaceutical Manufacturing industry.

What technology does Crossject use?

Minus sign iconPlus sign icon
Crossject 's tech stack includes jsDelivrcdnjsUnderscore.jsjQueryPythonBootstrapYouTubeApache.

What is Crossject 's email format?

Minus sign iconPlus sign icon
Crossject 's email format typically follows the pattern of . Find more Crossject email formats with LeadIQ.

How much funding has Crossject raised to date?

Minus sign iconPlus sign icon
As of October 2024, Crossject has raised $7.5M in funding. The last funding round occurred on Jul 10, 2024 for $7.5M.

When was Crossject founded?

Minus sign iconPlus sign icon
Crossject was founded in 2001.
Crossject

Crossject

Pharmaceutical ManufacturingBourgogne, France51-200 Employees

Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal insufficiencies, opioid overdose and asthma attacks.
 

Section iconCompany Overview

Headquarters
Parc MAZEN-SULLY 6-8 rue Pauline Kergomard Dijon, Bourgogne 21000 FR
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2001
Employees
51-200

Section iconFunding & Financials

  • $7.5M

    Crossject has raised a total of $7.5M of funding over 2 rounds. Their latest funding round was raised on Jul 10, 2024 in the amount of $7.5M.

Section iconFunding & Financials

  • $7.5M

    Crossject has raised a total of $7.5M of funding over 2 rounds. Their latest funding round was raised on Jul 10, 2024 in the amount of $7.5M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.